Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
Kakino R, Nakamura M, Mitsuyoshi T, Shintani T, Kokubo M, Negoro Y, Fushiki M, Ogura M, Itasaka S, Yamauchi C, Otsu S, Sakamoto T, Sakamoto M, Araki N, Hirashima H, Adachi T, Matsuo Y, Mizowaki T. Kakino R, et al. Among authors: mitsuyoshi t. Med Phys. 2020 Sep;47(9):4634-4643. doi: 10.1002/mp.14380. Epub 2020 Aug 2. Med Phys. 2020. PMID: 32645224
Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma.
Shinohara S, Takebayashi S, Hamaguchi K, Michida T, Tobe Y, Ikenaga T, Yasumoto M, Hamamoto A, Imagumbai T, Mitsuyoshi T, Ashida R, Iwai T, Okabayashi S. Shinohara S, et al. Among authors: mitsuyoshi t. Clin Med Insights Oncol. 2021 Oct 4;15:11795549211048417. doi: 10.1177/11795549211048417. eCollection 2021. Clin Med Insights Oncol. 2021. PMID: 34629923 Free PMC article.
Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study).
Mitsuyoshi T, Ono Y, Ashida R, Yamashita M, Tanabe H, Takebe S, Tokiwa M, Suzuki E, Imagumbai T, Yoshimura M, Yamauchi C, Mizowaki T, Kokubo M. Mitsuyoshi T, et al. Jpn J Clin Oncol. 2023 Jan 28;53(2):174-178. doi: 10.1093/jjco/hyac174. Jpn J Clin Oncol. 2023. PMID: 36420578 Free PMC article. Clinical Trial.
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study.
Tokuda PJK, Mitsuyoshi T, Ono Y, Kishi T, Negoro Y, Okumura S, Ikeda I, Sakamoto T, Kokubo Y, Ashida R, Imagumbai T, Yamashita M, Tanabe H, Takebe S, Tokiwa M, Suzuki E, Yamauchi C, Yoshimura M, Mizowaki T, Kokubo M; Kyoto Radiation Oncology Study Group. Tokuda PJK, et al. Among authors: mitsuyoshi t. Breast Cancer. 2024 Jul;31(4):643-648. doi: 10.1007/s12282-024-01577-3. Epub 2024 Apr 12. Breast Cancer. 2024. PMID: 38607499 Free PMC article. Clinical Trial.
Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab.
Shintani T, Kishi N, Matsuo Y, Ogura M, Mitsuyoshi T, Araki N, Fujii K, Okumura S, Nakamatsu K, Kishi T, Atsuta T, Sakamoto T, Narabayashi M, Ishida Y, Sakamoto M, Fujishiro S, Katagiri T, Kim YH, Mizowaki T. Shintani T, et al. Among authors: mitsuyoshi t. Clin Lung Cancer. 2021 Sep;22(5):401-410. doi: 10.1016/j.cllc.2021.01.017. Epub 2021 Feb 4. Clin Lung Cancer. 2021. PMID: 33678582
46 results